Scholarlink

<p>Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies worldwide, with cancer stemness and metastasis being critical factors contributing to poor prognosis. While circular RNAs are emerging as important regulators in cancer progression, the role of <i>circGIGYF1</i> in CRC development is poorly understood. Here, we found that downregulated <i>circGIGYF1</i> is linked to poor survival rate in CRC patients. <i>circGIGYF1</i> inhibits CRC stemness, epithelial-mesenchymal transition, and metastatic potential both in vitro and in vivo. Mechanistically, <i>circGIGYF1</i> promotes the interaction between WWP2 and HOXD13, enhancing HOXD13 ubiquitination and subsequent degradation. This degradation prevented HOXD13 from binding to the <i>CTNNB1</i> promoter, thereby suppressing Wnt/β-catenin signalling pathway activation. Importantly, <i>circGIGYF1</i> overexpression or <i>HOXD13</i> knockdown significantly reduces tumor growth and liver metastasis in mouse models. These findings reveal a <i>circGIGYF1/WWP2/HOXD13</i>/β-catenin regulatory axis in CRC progression and highlight <i>circGIGYF1</i> as a potential therapeutic target for developing strategies to combat CRC metastasis and recurrence.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

RETRACTED ARTICLE: circGIGYF1 inhibits stemness and metastasis in colorectal cancer by promoting WWP2-HOXD13 interaction to regulate β-catenin signalling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Bin Zhao,
  • Jiacheng Li,
  • Zunxian Wang,
  • Hairui Zhou,
  • Zhuoxin Cheng,
  • Shuxia Ma

摘要

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies worldwide, with cancer stemness and metastasis being critical factors contributing to poor prognosis. While circular RNAs are emerging as important regulators in cancer progression, the role of circGIGYF1 in CRC development is poorly understood. Here, we found that downregulated circGIGYF1 is linked to poor survival rate in CRC patients. circGIGYF1 inhibits CRC stemness, epithelial-mesenchymal transition, and metastatic potential both in vitro and in vivo. Mechanistically, circGIGYF1 promotes the interaction between WWP2 and HOXD13, enhancing HOXD13 ubiquitination and subsequent degradation. This degradation prevented HOXD13 from binding to the CTNNB1 promoter, thereby suppressing Wnt/β-catenin signalling pathway activation. Importantly, circGIGYF1 overexpression or HOXD13 knockdown significantly reduces tumor growth and liver metastasis in mouse models. These findings reveal a circGIGYF1/WWP2/HOXD13/β-catenin regulatory axis in CRC progression and highlight circGIGYF1 as a potential therapeutic target for developing strategies to combat CRC metastasis and recurrence.